A lead-free, ceiling-mounted shielding system could significantly reduce occupational radiation exposure among physicians performing fluoroscopy-guided procedures, according to a study presented at TCT 2026.
Men are much more likely to have degenerative mitral valve disease than men, according to a new global analysis presented at TCT 2026 in San Diego. However, women are more likely to die from it.
TAVR may be a safe, effective treatment strategy for patients with moderate aortic stenosis and at least one other warning sign of heart disease. That was the key takeaway from a highly anticipated late-breaking study presented by Philippe Généreux, MD, at TCT 2026 in San Diego.
The upfront costs may be higher, but new data presented at TCT 2026 showed that treating asymptomatic patients with TAVR instead of clinical surveillance was a highly cost-effective intervention.
The new device can treat varying anatomies and is able to compensate for native leaflet abnormalities. It was also designed to be gentle on a patient's anatomy.
Alasnag, a veteran interventional cardiologist and women's health advocate, has won the 2027 Dr. Carolyn McCue Award for Woman Cardiologist of the Year. She directs the cardiac cath lab at King Fahd Armed Forces Hospital in Jeddah, Saudi Arabia.
“A drug that can both decrease the risk for diabetes along with the risk for having a heart attack or stroke could be a turning point in our ability to safely treat this growing population in the U.S. and abroad,” one researcher said.
Traditionally, the interventional cardiologist first visualizes the coronary anatomy in detail when contrast is injected in the catheterization laboratory. For many patients, however, that anatomy has already been captured, often in considerable detail, by coronary CT angiography (CCTA) performed earlier in the clinical pathway. This article considers how this dataset can be used to plan the procedure, an approach referred to as CT-guided PCI.
